[Effects of inhaled corticosteroids/long-acting beta-2 agonist fix combinations in COPD]. / KOAH'da inhaler kortikosteroid/uzun etkili beta-2 agonist fiks kombinasyonunun etkileri.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease characterized with progressive air flow limitation, and is expected to be the third leading cause of death until 2030 worldwide. The clinical trials in the last 10 years revealed that fix combinations (inhaled corticosteroids/long-acting beta-2 agonist; ICS/LABA) improve lung functions and quality of life, and reduced symptoms and exacerbation rates in patients with severe and very severe COPD.